SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-016160
Filing Date
2013-03-19
Accepted
2013-03-19 16:33:51
Documents
1
Period of Report
2013-03-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v338555_4.html 4  
1 OWNERSHIP DOCUMENT v338555_4.xml 4 3219
  Complete submission text file 0001144204-13-016160.txt   4867
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019
Business Address
SCHOENEBAUM MARK (Reporting) CIK: 0001548537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32639 | Film No.: 13702206